Académique Documents
Professionnel Documents
Culture Documents
ABSTRACT
PRACTICAL APPLICATIONS
INTRODUCTION
Milk is the complete source of nutrients for the neonate, which provides
proteins, lipids, sugars, vitamins and minerals for healthy growth of an infant
(Warner et al. 2001). The newborn human has an immature digestive capacity
in the stomach and small intestine, resulting in a high proportion of intact or
large fragments of food protein molecules passing through the intestinal
mucosal barrier into the immune structures in the intestinal lining (Peyer’s
patches) or into the blood. These intact proteins or large peptides may act as
antigens to the immune system of the young, resulting in allergic hypersensi-
tivity reactions and food protein intolerance. Cow milk proteins belong to the
strongest antigens in human diet (Eigel et al. 1984). Milk proteins are the first
exogenous proteins consumed in large quantities by children (Järvinen and
Suomalainen 2001). Whey proteins (a-lactalbumin [ALA], b-lactoglobulin
[BLG], bovine serum albumin) and caseins are considered as the main cow’s
milk antigens (Räsänen et al. 1992; Nentwich et al. 2004), and they cause an
immunologically mediated adverse reaction (Savilahti et al. 1992).
Nowadays, the cow’s milk allergy ranges from 1.9 to 7.5% of the popu-
lation (Järvinen and Suomalainen 2001). For this reason, the application of
lactic acid bacteria (LAB) in hydrolysis of milk proteins may have important
effects on milk digestibility, on the production of bioactive peptides and may
decrease milk allergenicity and lactose intolerance (Nentwich et al. 2004;
Prioult et al. 2005). Humans have used yogurt and yogurt-like products as the
most popular vehicles for ingestion of probiotic microorganisms. Probiotics
have been the subject of considerable scientific and commercial attention over
the past two decades. Probiotics are live microorganisms that when ingested
682 I. TZVETKOVA ET AL.
may have positive effects on human health (Fuller 1991). Beneficial effects
of probiotics on immune-mediated diseases, such as allergy, have been
documented and include stimulating the immune system (Cross et al. 2001;
Ouwehand et al. 2002), synthesizing and increasing the bioavailability
of nutrients (Pessi et al. 1998) and decreasing the prevalence of atopy
(Kalliomäki et al. 2001). Bifidobacteria and lactobacilli are common anaer-
obes in the human intestinal microbiota, and some of them have been reported
to display probiotic properties (Ouwehand et al. 1999). Although LAB are
usually considered to be only weakly proteolytic, some of them cause a
significant degree of proteolysis in multiple fermented dairy products includ-
ing yogurts. Yogurt bacteria are microorganisms with multiple amino acid
auxotrophies (Kok and De Vos 1994). The content of free amino acids and
peptides in milk is insufficient (Zourari et al. 1992; Abu-Tarboush 1996);
therefore, many LAB possess a complex system of proteinases and peptidases,
which enable them to produce essential amino acids during their growth in
milk (Kunji et al. 1996; Chen and Steele 1998).
The proteolytic activities of LAB including yogurt bacteria and probiotic
bacteria have been studied extensively (Booth et al. 1990; Wohlrab and
Bockelmann 1993; Bockelmann et al. 1996; Law and Haandrikman 1997; Ehn
et al. 2005).
Additionally, proteolytic enzymes from LAB produce flavor compounds
and precursors that are essential for cheese flavor development (Mulholland
1997; Chen and Steele 1998). The proteolytic systems of LAB can be func-
tionally divided into three components: (1) cell envelope-associated protein-
ases, which hydrolyze caseins to oligopeptides; (2) peptide transport systems,
of which the oligopeptide transport system is the most important in milk and
cheese; and (3) numerous intracellular peptidases (Kunji et al. 1996; Chen and
Steele 1998). The intracellular peptidases of LAB include both endopeptidases
and aminopeptidases. Endopeptidases, because of their ability to hydrolyze
peptide bonds within a peptide, are of particular interest in targeting peptides
for rapid hydrolysis.
To promote human health, combinations of different bacterial strains
belonging to the genera Lactobacillus, Streptococcus and Bifidobacterium
have been used traditionally in fermented dairy products (Prasad et al. 1998;
Dunne et al. 1999). A variety of LAB isolated from fermented milk products
have been previously reported as displaying beneficial functions for humans,
including antimicrobial (Sandine et al. 1972; Eijsink et al. 1998), antitumor
(Kelkar et al. 1988; Hosono et al. 1990; Adachi 1992) and antimutagenic
activities (Nishioka et al. 1989; Hosono et al. 1990), as well as effects on
modulating the immune system (Perdigon et al. 1988; Fernandes and Shahani
1990), lowering cholesterol levels (Shun et al. 1989) and reducing lactose
intolerance in the host (Alm 1982). Lactobacillus is the most important group
MILK PROTEINS PROTEOLYSIS BY LAB 683
of starters for the dairy industry. During fermentation process, milk proteins
are acidified by the production of lactic acid and are hydrolyzed by proteases
and peptidases from bacteria. This proteolysis is followed by a reduction of the
number of epitopes and consequently by a decrease in allergenicity of hydro-
lyzed proteins (Cross et al. 2001; Bertrand-Harb et al. 2003; Nentwich et al.
2004). For these reasons, starters as Lactobacillus strains with beneficial
properties able to reduce the allergenicity of fermented milk products are of
great interest for the dairy industry.
In this study, the attention was focused on homemade yogurts from the
Balkan region, as a source of newly potential starters for application in the
food industry. In this context, the aim of this study was to screen the pro-
teolytic activity of newly isolated strains, by determination of the optimal
conditions of proteolysis for reducing milk protein allergenicity.
Proteolytic Activity
Initial screening of the strains for the presence of proteolytic activity was
performed using the well diffusion method (Schillinger and Lucke 1989). A
1.4% skim milk agar was used. Wells were made in the lawn of hardened soft
684 I. TZVETKOVA ET AL.
Antimicrobial Assay
Antimicrobial assay was performed as previously described (Bertrand-
Harb et al. 2003) by the well diffusion method by using soft 0.8% agar. After
adjusting the pH at 6.5 by NaOH, the activity of the collected samples (60 mL)
was checked against E. coli American Type Culture Collection 25922 on
Luria–Bertani agar medium (Sigma, St. Louis, MO) and against Listeria
innocua F (Ecole Nationale des Ingénieurs des Techniques des Industries
Agricoles et Alimentaires, Nantes, France) on brain–heart agar medium
(Biokar Diagnostics, Beauvais, France). The plates were incubated overnight
at 37C.
Antimicrobial activity of 24- and 48-h hydrolyzed samples was checked
on the strains cultured on media containing 2% glucose in 100-mM phosphate
buffer added with 0.08, 0.5 and 2.0% sodium caseinate. The neutralized
supernatants (pH 6.5) obtained after 24-h preculture in MRS, and after 4-, 6-
and 24-h culture in milk were also checked for their activity against E. coli.
All experiments were performed in triplicate.
686 I. TZVETKOVA ET AL.
API Tests
API tests showed that all the strains tested are Lactobacillus delbrueckii
ssp. bulgaricus.
Proteolytic Activity
The initial screening of the strains tested on skim milk agar for their
proteolytic activity showed that all the strains have a proteolytic activity and
generate a clear zone even after 4 h of incubation (data not shown).
β-Casein
αS-Casein
K2 K3 K5 K6 K14 K15 K19 K20 K21 C K22 K24 K26 K27 O42 O43 O45 O47 B5 C B7 B8 C
β-Casein
αS-Casein
K2 K3 K5 K6 K14 K15 K19 C K20 K21K22 K24 K26 K27 O42 043 C O45 O47 B5 B7 B8
β-Casein
αS-Casein
K3 K5 K6 K14 K15 K19 K20 K21K22 C K24 K26 O42 043 045 O47 B5 B7 B8 C K2 B5 K27C
β-Casein
αS-Casein
K2 K3 K5 K6 K14 K15 K19 K20 K21C K22 K24 K26K27 O42 043 O45 O47 B5 C B8 B7
disappeared after longer incubation. This finding supports the fact that the
proteases present in the different strains conserved well their hydrolytic
activities.
The time course of b-casein degradation during incubation period is
shown in Fig. 2. The intensity of degradation of b-casein depends on the
strain used. However, after 96 h of incubation, 80–90% of b-casein was
digested by all the strains tested, as estimated by using Quantity One BioRad
Software.
120
100
beta-casein(%)
80 Strain K2
Strain K3
Strain K5
60 Strain K6
Strain K14
Strain K15
40 Strain K19
Strain K20
Strain K21
20 Strain K22
Control
A
0
0 20 40 60 80 100
Time (h)
120
100
Strain K24
beta-casein (%)
80 Strain K26
Strain K27
Strain O42
60 Strain O43
Strain O45
Strain O47
40 Strain B5
Strain B7
Strain B8
20 Control
B
0
0 20 40 60 80 100
Time (h)
K5 K3 K14 C ALA M K21 O45 O42 K2 K26 K6 C ALA M K22 K15 K19 B5 K20 K24 B7 K27 C M
Control
100 O43
O47
K5 O42 O45 B8
K2 K21
80 B5
K26
K19
K3 K6 K22 B7
ALA (%)
K15 K24
60 K14 K20
K27
40
20
After 24 h incubation
The three strains K5, K19 and K27 showed similar results. They were
growing on medium containing either sodium caseinate or b-casein. The time
course of b-casein degradation obtained by urea-PAGE (Fig. 7, insert) shows
that after 6 h of incubation, a new band with a higher electrophoretic mobility
appeared. b-Casein band disappeared almost completely after 48 h of incuba-
tion in the case of the strain K27. After 96-h incubation, the three selected
strains cultivated either on b-casein or on sodium caseinate showed the same
results.
MILK PROTEINS PROTEOLYSIS BY LAB 691
Control
100
K6 K20 K26
O45
K3 K14 K21 O42O43 O47
K2 K5 K19 K24 K27
B8
80 K15 B7
K22 B5
BLG(%)
60
40
20
After 24 h incubation
FIG. 4. SODIUM DODECYL SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS
(SDS-PAGE) AND RELATIVE QUANTIFICATION OF b-LACTOGLOBULIN (BLG) IN
SAMPLES OBTAINED AFTER 24-H CULTIVATION OF THE STRAINS IN THE PRESENCE
OF 0.1% BLG
The strains with prefixes “K,” “O” and “B” correspond to strains isolated from cow, sheep and
buffalo yogurts, respectively. Thirty microliters of the culture supernatant was diluted with 90-mL
SDS-PAGE sample buffer containing 4% sodium dodecyl sulfate, 3% 2-mercaptoethanol, 10%
glycerol, 50-mM Tris–HCl, pH 6.8.
M, milk; C, control (a medium with BLG, without bacteria).
692 I. TZVETKOVA ET AL.
b-casein
aS-casein
K2 K3 K5 K6 K14 K15 K19 K20 K21 C K22 K24 K26 K27 O42 O43 O45 O47 B5 C B7 B8 C
b-casein
aS-casein
K2 K3 K5 K6 K14 K15 K19 K20 K21 C K22 K24 K26 K27 O42 O43 O45 O47 B5 C B7 B8 B8 C
b-casein
aS-casein
K2 K3 K5 K6 K14 K15 K19 K20 K21 C K22 K24 K26 K27 O42 O43 O45 O47 B5 C B7 B8 C
b-casein
aS-casein
K2 K3 K5 K6 K14 K15 K19 K20 K21 C K22 K24 K26 K27 O42 O43 O45 O47 B5 C B7 B8 C
100
80
Strain K2
beta-casein (%)
Strain K3
Strain K5
60 Strain K6
Strain K14
Strain K15
40 Strain K19
Strain K20
Strain K21
Strain K22
20 Control
A
0
0 20 40 60 80 100
Time (h)
100
80
Strain K24
beta-casein (%)
Strain K26
Strain K27
60 Strain O42
Strain O43
Strain O45
40 Strain O47
Strain B5
Strain B7
Strain B8
20 Control
B
0
0 20 40 60 80 100
Time (h)
0.4 0.4
6h 24 h
0.3 0.3
AU
AU
0.2 0.2
0.1 0.1
0.0 0.0
0 10 20 30 40 0 10 20 30 40
0.3 0.3
AU
AU
0.2 0.2
0.1 0.1
0.0 0.0
0 10 20 30 40 0 10 20 30 40
0.3
AU
0.2 6h 24 h 48 h 72 h
96 h
K5
0.1 K19
K27
Control
0.0
0 10 20 30 40
Time (min)
CONCLUSIONS
6h 24 h
0.6 0.6
0.4 0.4
AU
AU
0.2 0.2
0.0 0.0
0 10 20 30 40 0 10 20 30 40
48 h 72 h
0.6 0.6
0.4 0.4
AU
AU
0.2 0.2
0.0 0.0
0 10 20 30 40 0 10 20 30 40
96 h
0.6 1 2 3 4 5 6 7 8 9 10 11 12 13 1415 16 17 18 1920
0.4
AU
6h 24 h 48 h 72 h 96 h
0.2
K5
K19
K27
0.0 Control
0 10 20 30 40
Time (min)
FIG. 9. ANTIMICROBIAL ACTIVITY AGAINST (A) ESCHERICHIA COLI AND (B) LISTERIA
INNOCUA OF STRAINS CULTIVATED FOR 48 H ON 2% SODIUM CASEINATE, 2%
GLUCOSE IN 100-mM PHOSPHATE BUFFER
698 I. TZVETKOVA ET AL.
was consumed by the strains. The strain K27 analyzed by RP-HPLC and
urea-PAGE showed the highest proteolytic activity.
The strains tested showed proteolytic activity toward ALA. They were
able to reduce the concentration of ALA in the medium between 5 and 55%,
depending on the strains used. The strains K14 and K27 showed the highest
proteolytic activity being able to reduce the concentration of ALA approxi-
mately by 50%.
The capacity of the strains to hydrolyze BLG was lower as compared with
ALA. Even if ALA was more easily degradable by the bacteria, the strain K26
was able to reduce by 30% the level of BLG in the medium.
The beginning of casein degradation was delayed when the cells were
washed before inoculation of the test medium. RP-HPLC analysis confirmed
that, as a result of proteolysis by the tested strains, b-casein was cleaved into
more hydrophilic protein, which suggests that the strains tested possess also an
exopeptidase activity.
The hydrolysis of casein by all the strains tested produced peptides with an
antibacterial effect against E. coli. The neutralized supernatants from the strains
K2 and K22 grown on MRS also had an activity against E. coli that indicates the
presence of antibacterial substances of bacterial origin (bacteriocins).
Consequently, to obtain the most beneficial effect, a combination of
strains with different properties could be used as starters.
ACKNOWLEDGMENTS
REFERENCES
ANDREWS, A.T. 1983. Proteinases in normal bovine milk and their action on
caseins. J. Dairy Res. 50, 45–55.
BERTRAND-HARB, C., IVANOVA, I.V., DALGALARRONDO, M. and
HAERTLÉ, T. 2003. Evolution of b-lactoglobulin and a-lactalbumin
content during yoghurt fermentation. Int. Dairy J. 13, 39–45.
BOCKELMANN, W., HOPPE-SEYLER, T. and HELLER, K.J. 1996. Purifi-
cation and characterization of an endopeptidase from Lactobacillus
delbrueckii subsp. bulgaricus. Int. Dairy J. 6, 1167–1180.
BOOTH, M., JENNINGS, V., NI FHAOLAIN, I. and O’CUINN, G. 1990.
Prolidase activity of Lactococcus lactis subsp. cremoris AM2: Partial
purification and characterization. J. Dairy Res. 57, 245–254.
CHEN, Y.-S. and STEELE, J.L. 1998. Genetic characterization and physi-
ological role of endopeptidase O from Lactobacillus helveticus CNRZ32.
Appl. Environ. Microbiol. 64, 3411–3415.
CROSS, M.L., STEVENSON, L.M. and GILL, H.S. 2001. Anti-allergy prop-
erties of fermented foods: An important immunoregulatory mechanism of
lactic acid bacteria? Int. Immunopharmacol. 1, 891–901.
DUNNE, C., MURPHY, L., FLYIN, S., O’MAHONY, L., O’HALLORAN,
S., FEENEY, M., MORRISEY, D., THORTON, G., FITZGERALD, G.,
DALY, C. ET AL. 1999. Probiotics: From myth to reality. Demonstration
of functionality in animal models of disease and in human clinical trials.
Antonie Van Leeuwenhoek 76, 279–292.
EHN, B.-M., ALLMERE, T., TELEMO, E., BENGTSSON, U. and
EKSTRAND, B. 2005. Modification of IgE binding to b-lactoglobulin by
fermentation and proteolysis of cow’s milk. J. Agric. Food Chem. 53,
3743–3748.
EIGEL, W., BUTLER, J.E., ERNSTROM, C.A., FARRELL, H.M.J.R.,
HARWALKAR, V.R., JENNES, R. and WHITNEY, R.M.C.L. 1984.
Nomenclature of proteins of cow’s milk: Fifth revision. J. Dairy Sci. 67,
1599–1631.
EIJSINK, V.G., SKEIE, M., MIDDELHOVEN, P.H., BRURBERG, M.B. and
NES, I.F. 1998. Comparative studies of class IIa bacteriocins of lactic
acid bacteria. Appl. Environ. Microbiol. 64, 3275–3281.
FERNANDES, C.F. and SHAHANI, K.M. 1990. Anti-carcinogenic and
immunological properties of dietary lactobacilli. J. Food Prot. 53, 704–
710.
FULLER, R. 1991. Probiotics in human medicine. Gut 32, 439–442.
HOSONO, A., WARDOJO, R. and OTANI, H. 1990. Inhibitory effects of
lactic acid bacteria from fermented milk on the mutagenicities of volatile
nitrosamines. Agric. Biol. Chem. 54, 1639–1643.
JÄRVINEN, K.-M. and SUOMALAINEN, H. 2001. Development of cow’s
milk allergy in breast-fed infants. Clin. Exp. Allergy 31, 978–987.
MILK PROTEINS PROTEOLYSIS BY LAB 701